Glucose Injection27

1. Product Name:Glucose Injection

2. Product Description: Glucose injection Description A colorless or nearly colorless transparent liquid. ? Introduction Glucose Injection, in the MINI-BAG Plus Container is a sterile, nonpyrogenic solution ?for intravenous administration after admixture with a single dose powdered drug. ? Indication and usage Glucose Injection, is indicated as a source of water and calories and may also be used as diluent for reconstitution of a powdered drug product packaged in a vial with a 20 mm closure. . Dosage and Administration To Open Tear overwrap down side at slit and remove solution container. Visually inspect the container. If the port protector is damaged, detached, or not present, discard container as solution path sterility may be impaired. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity should diminish gradually. Prior to use, check that the vial adaptor cover is intact. Check the solution container for minute leaks by squeezing inner bag firmly. If leaks are found or if the vial adaptor cover is not intact, discard product as sterility may be impaired. To Assemble and Reconstitute See other side for detailed instructions. Additives may be incompatible. . Adverse Reactions Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary. . Contraindication Solutions containing glucose may be contraindicated in patients with known allergy to corn or corn products. ? Clinical Pharmacology Glucose Injection,has value as a source of water and calories. It has a caloric content of approximately 170 kcal/L. It is capable of inducing diuresis depending on the clinical condition of the patient. ? Precautions Dextrose Injections should not be administered simultaneously with blood through the same administration set because of the possibility of pseudoagglutination or hemolysis. The intravenous administration of these solutions can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states, or pulmonary edema. The risk of dilutive states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injections. Excessive administration of Dextrose Injections may result in significant hypokalemia. For use only with a single dose powdered drug vial with a 20 mm closure. Do not administer unless drug is completely dissolved and drug vial is empty. Additives may be incompatible. Do not remove drug vial at any time prior to or during administration. In very low birth weight infants, excessive or rapid administration of Dextrose Injection may result in increased serum osmolality and possible intracerebral hemorrhage Related Keywords: China glucose injection manufacturer,China glucose injection suppliers,glucose injection from China professional pharmaceutical factory,one of the glucose injection leading brands from China,glucose injection manufacturers,China glucose injection,Glucose Injection,dextrose

3. Price:10.00

4. Product Website: http://www.sundentpharm.com/vitamin-and-nutrition/glucose-injection.html

5. Company Description: Sundent Pharm Group

6. Address: ShanghaiShanghaiShanghaiSongjiangNo.1333 Xinlong Road, Shanghai.China.

7. Descption: Sundent Pharm Group (together with its subsidiaries, the Group”) is one of the largest comprehensive manufacturing, marketing, promotion and channel management service provider dedicated to pharmaceutical products.? Since establishment in 2004, the Group has determined to apply global vision to local management, and has introduced a series of pharmaceutical products embedded with technologies that represent international advanced level to China, South America, Eastern European and south Asia countries.? As of Dec 2015, the company had portfolio of pharmaceutical products, covering pain management, cardiovascular, respiratory, gastroenterology, immunology and other therapeutic areas.? At the same time, the Group endeavors to uplift the market value of these brands. With a global horizon and well-deserved creditability in international market development, the Group has established long-term and stable cooperation with a number of renowned Chinese pharmaceutical manufacturer leaders, independent product quality analysis and develop centers, Chinese SFDA etc., The network lays the foundation of the sustainable development of the company through the comprehensive and effective products introduction and cooperation. Looking into the future, the Group is committed to build itself into a cutting-edge pharmaceutical manufacturing and marketing group company that grasps the sales channel and product pricing advantage in mainland China. We believe that, with rapid development of China's pharmaceutical industry, through an open-minded attitude, perspective new product introduction capability, accurate product marketing strategy, comprehensive marketing network and effective management system, Sundent Pharmaceutical Group is able to achieve our development target.

8. Registered Capital: 50

9. EmployeeNum: 50

Sundent Pharm Group

10. Contact: Tracy zhang

11. Telphone: 86-21-67897115

12. Fax: 86-21-67897115

13. Email: Sundent@aliyun.com

14. Company Website: http://www.sundentpharm.com